Back to products
PA-2TRZ
PA-2TRZ Price range: $ 125 through $ 400

Wolverine BPC 157/TP 500 Oral

$ 275

Category:
Description

Wolverine BPC 157/TP 500 Oral Wolverine Stack is an investigational dual-peptide oral formulation featuring BPC-157 and TB-500, powered by our proprietary AQA™ (AQASOME™ Nanoparticle Carrier) technology. Developed with a focus on formulation innovation, quality, and consistency, it reflects the next generation of oral peptide delivery. Supplied for in vitro binding assays, receptor selectivity profiling, structural analysis and analytical method development by qualified laboratories. Not for use in any living organism

 

BPC-157 / TB-500 Blend 30/30mg

A research peptide blend combining two of the most extensively studied peptides in cellular and tissue research literature. Each vial contains 10mg BPC-157 and 10mg TB-500 (20mg total) in lyophilized form, manufactured in cGMP-compliant U.S. facilities

About the Compounds

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide composed of 15 amino acids, derived from a partial sequence of body protection compound originally isolated from human gastric juice. BPC-157 has been extensively studied in cellular research literature examining tissue research pathways, angiogenic signaling, nitric oxide pathway interactions, and cellular biology applications.

TB-500 (Thymosin Beta-4 fragment) is a synthetic 17-amino acid peptide fragment representing the active actin-binding region of Thymosin Beta-4, a naturally occurring protein found in nearly all human and animal cells. TB-500 has been studied in research literature examining actin cytoskeletal dynamics, ce

Research Background

This blend is supplied for laboratories conducting comparative cellular research involving both BPC-157 and TB-500. The combined formulation allows researchers to study both compounds within a single sample preparation, streamlining laboratory workflows for parallel peptide research applications.

Foundational research on both compounds is available through PubMed (pubmed.ncbi.nlm.nih.gov) and the National Institutes of Health’s PMC database (pmc.ncbi.nlm.nih.gov), where researchers can access peer-reviewed literature including:

  • Foundational research on BPC-157 cellular biology by Sikiric et al. at the University of Zagreb
  • Foundational research on Thymosin Beta-4 and its derivative peptides by Goldstein et al.
  • Comparative peptide research on cellular signaling and actin-binding mechanisms